Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Tables)

v3.19.1
Shareholders' Deficit (Tables)
 12 Months Ended
Dec. 31, 2018
Equity [Abstract]
Schedule of nonvested activity

Number of

Non-vested Shares

 Weighted Average Grant Date Fair Value
Nonvested, December 31, 2017 - $ -
Granted 6,483,732 0.62
Forfeited (485,060 ) 0.85
Nonvested, December 31, 2018 5,998,672 $ 0.61
Schedule of stock option activities
Number of Options Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value
Balance Outstanding December 31, 2016 10,564,213 $ 0.42
Granted 4,330,000 0.29
Balance Outstanding December 31, 2017 14,894,213 0.32
Exercised (1,757,032 ) 0.12
Forfeited (1,691,483 ) 0.66
Balance Outstanding December 31, 2018 11,445,698 $ 0.30 6.70 $ 3,291,240
Exercisable, December 31, 2018 9,471,195 $ 0.28 6.28 $ 2,844,028
Schedule of warrant activities
Number of Warrants Weighted Average Exercise Price Weighted Average Remaining Contractual Term (Years) Aggregate Intrinsic Value
Balance Outstanding December 31, 2017 - $ - - $ -
Granted 293,123 0.87
Cancelled (293,123 ) (0.87 )
Balance Outstanding December 31, 2018 - $ - - $ -
Exercisable, December 31, 2018 - $ - - $ -